Regulation for multidrug resistant cancer and cancer stem cells by ABC transporter-targeted virus
Regulation for multidrug resistant cancer and cancer stem cells by ABC transporter-targeted virus
批准号:
18590315
负责人:
NAKANO Kenji
金额:
$2.63万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The purpose of current study was to examine the specificity and efficacy of targeted therapeutic molecule for EGFR-overexpressing cancer cells, in stead of ABCG2-positive cancer stem cells due to technical difficulty in culture.1) Comparison for targeting ligand of single chain of antibody against EGFR versus EGFWe constructed two types of adapters comprising of nectin1-V-domain fused to a single chain of antibody (scFv) against EGFR or a natural ligand, EGF. The efficacy of adapter-mediated HSV infection was significantly higher when HSV was challenged with the scFv-adapters than EGF-adapters. The potential factors for the differential entry efficiency seem to be the followings.a) The scFv-adapter had a higher affinity to HSV-gD than EGF-adapter although the affinity to EGFR was similar.b) The scFv-adapter did not induce the activation of EGFR so much as the EGF-adapter.c) The EGF-adapter was rapidly degraded in endosome-lysosome pathway, whereas the scFv-adapter was resistant at the … More same time points by 30 min post-binding.The scFv-adapter is superior to the EGF-adapter as a targeting ligand for EGFR-mediated HSV infection. (Under manuscript preparation)2) Efficacy of EGFR-targeted suicide gene therapyWe constructed the expression plasmid for EGFR scFv-fused to E. coli PNP suicide gene and CA19-9 scFv-fused to E. coli PNP as the control, and then established colon cancer cell lines stably expressing the suicide genes. The efficacy of targeted suicide gene therapy for EGFR-overexpressing cancer was compared between the two targeting ligands. Tumor growth was more inhibited by the both suicide gene therapies compared with the saline control. EGFR scFv-fused to PNP suicide gene therapy induced a complete regression in some of mice harboring subcutaneous EGFR-overexpressing colon cancer and exhibited higher therapeutic efficacy than the control of CA19-9 scFv-fused suicide gene therapy. Immnofluorescence staining showed the co-localization of suicide gene expression and tumor vessels when provided with EGFR scFv-fused suicide gene but not much with CA 19-9 scFv-fused suicide gene (Biotherapy 21; 229-34, 2007) Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
癌に対するウイルス・遺伝子治療の現状と展望
癌症病毒/基因治疗的现状与展望
DOI:
--
发表时间:
2008
期刊:
医事新報 4639
影响因子:
--
作者:
[中野賢二, 田原秀晃]
通讯作者:
田原秀晃
DOI:
--
发表时间:
2008
期刊:
Japan Medical Journal 4639
影响因子:
--
作者:
[Nakano K, Tahara H.]
通讯作者:
Tahara H.
抗体分子・細胞デリバリーシステムの標的化がん治療への応用
抗体分子和细胞递送系统在癌症靶向治疗中的应用
DOI:
--
发表时间:
2007
期刊:
Biotherapy 21
影响因子:
--
作者:
[中野賢二, 田原秀晃, 中野賢二]
通讯作者:
中野賢二
抗体分子vs EGFリガンド : EGFRに対する標的化分子としての有用性の比較
抗体分子与 EGF 配体:比较它们作为 EGFR 靶向分子的用途
DOI:
--
发表时间:
2008
期刊:
影响因子:
--
作者:
[中野賢二, 田原秀晃]
通讯作者:
田原秀晃
消化器がん 化学療法 2006 「消化器がんにおける分子標的治療」
胃肠癌化疗2006年《胃肠癌分子靶向治疗》
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[中野賢二, 藤井輝彦, 山名秀明, 桑野信彦]
通讯作者:
桑野信彦
共 10 条
Detection of cancer stem cells and minimal invasion by DNP-MRI and hyperspectral enodoscopy redox imaging
-
批准号:26670016
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2014
-
负责人:NAKANO Kenji
-
依托单位:
Development of YB-1-silencing miRNA/ decoy gene therapy against intractable solid tumor to regulate malignant microcircumstances
-
批准号:24390322
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.73万
-
财政年份:2012
-
负责人:NAKANO Kenji
-
依托单位:
Non-invasive assessment for therapeutic response to gene therapy using redox imaging and MALDI-TOF mass-spectrometry
-
批准号:22659111
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.06万
-
财政年份:2010
-
负责人:NAKANO Kenji
-
依托单位:
Oncolytic virus therapy for biliary and pancreas cancer using a replication-competent herpes simplex virus mutant and proapoptotic reagent
-
批准号:13671310
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2001
-
负责人:NAKANO Kenji
-
依托单位:
国内基金
海外基金
Pre-targeting/Click反应介导的自体循环干细胞在心脏缺血损伤修复中的应用及机制研究
-
批准号:81873493
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:沈德良
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: